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Currently, there is a growing demand to determine the protective status of vaccinated
fish in order to prevent diseases outbreaks. A set of different parameters that include
the infectious and immunological status of vaccinated salmonids from 622 Chilean
farms were analyzed during 2011–2014. The aim of this study was to optimize the
vaccination program of these centers through the determination of the protective state of
vaccinated fish using oral immunizations. This state was determined from the association
of the concentration of the immunoglobulin M (IgM) in the serum and the mortality
rate of vaccinated fish. Salmonids were vaccinated with different commercial mono- or
polyvalent vaccines against salmonid rickettsial septicemia (SRS) and infectious salmon
anemia (ISA), first by the intraperitoneal injection of oil-adjuvanted antigens and then by
the stimulation of mucosal immunity using oral vaccines as a booster vaccination. The
results showed that high levels of specific IgM antibodies were observed after injectable
vaccination, reaching a maximum concentration at 600–800degree-days. Similar levels
of antibodies were observed when oral immunizations were administrated. The high
concentration of antibodies [above 2750 ng/mL for ISA virus (ISAv) and 3500 ng/mL for
SRS] was maintained for a period of 800degree-days after each vaccination procedure.
In this regard, oral immunizations maintained a long-term high concentration of anti-SRS
and anti-ISAv specific IgM antibodies. When the concentration of antibodies decreased
below 2000pg/mL, a window of susceptibility to SRS infection was observed in the farm,
suggesting a close association between antibody levels and fish protective status. These
results demonstrated that, in the field, several oral immunizations are essential to uphold
a high level of specific anti-pathogens antibodies and, therefore, the protective status
during the whole productive cycle.
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Introduction
The Salmon industry has significantly increased worldwide over the last two decades. In Chile,
the industry has rapidly grown becoming one of the most important factors in the country’s
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development. Different diseases may impact on the immune
balance of salmon that, eventually, will end up affecting its pro-
duction. Methods such as vaccination have improved salmon pro-
duction and have helped to prevent the excessive use of antibiotics
as a means to prevent diseases outbreaks. Piscirickettsia salmonis
and ISA virus (ISAv) provoke salmonid rickettsial septicemia
(SRS) and infectious salmon anemia (ISA), respectively, and have
caused severe outbreaks during the last 6 years in Chile, result-
ing in significant loss of salmon production. Vaccination against
these pathogens in farmed salmonids ismostly administered using
an inactivated bacteria or virus emulsified in an oil-adjuvanted
preparation given via an intraperitoneal (i.p) injection. Recently,
we have demonstrated that mucosal stimulation by oral vaccina-
tion against SRS is less stressful for fish, delivers strong protection
and is very safety (1). This vaccination method is advantageous
for both small-sized salmon and large-scale procedures, mak-
ing it ideal for successive long-term immunizations during the
sea-water growth stage. Although, different commercial vaccines
against P. salmonis and ISAv present high degrees of protection
under experimental conditions, the efficacy of vaccination in the
field will depend on several factors such as the vaccination pro-
cedures used, the immunobiology of the fish, time of vaccination,
and environmental factors (2, 3). The study of the fish’s immune
response is an area of particular interest to the aquaculture indus-
try, especially the duration of immunity after vaccination. One
of the main problems to do this is the absence of information to
indicate changes in the protection status of salmonids during the
course of their production cycle.
The immune system of teleost fish has some similarities to
that of mammals’, where immunoglobulins are one of the most
important components of the immune response. In salmonids,
most of the current vaccines protect throughneutralizing antibod-
ies, either to prevent the infection from spreading or to interfere
the action of microbial products. Tetrameric immunoglobulin M
(IgM) is the prevailing class in serum, which increases signifi-
cantly upon infection or vaccination. The immunological protec-
tion after vaccination is often a relative aspect because it depends
on several factors such as host response, infection threshold, and
the complexity of the immune response (4). However, in most
cases, a high concentration of specific IgM antibodies can be
associatedwith a protective state in vaccinated fish. Indeed, several
studies have been carried out to relate specific serum IgM levels
and the protective capacity of vaccines against different pathogens
(5–10). However, these reports only studied the efficacy of vacci-
nation under experimental conditions, and none of them focused
on the field studies, where several factors may affect fish immune
response and protection elicited by the vaccine.
In the present work, we studied the protective state of vac-
cinated salmonids from several aquaculture farms in Chile, by
examining the association between antibody levels after vacci-
nation and mortality rate due to SRS. We analyzed, at various
degree-days, specific serum IgM levels against P. salmonis and
ISAv, in order to establish an appropriate vaccination program
that indicates the minimum IgM concentration necessary to pro-
mote immunological protection and to avoid infectious outbreaks,
especially against SRS and ISAv. In addition, we evaluated the
use of oral immunization as a measure to maintain a high-IgM
level along the entire productive cycle. We developed and used a
quantitative IgM enzyme-linked immunosorbent assay (ELISA)
to assess the levels of specific antibodies in the vaccinated fish.
Materials and Methods
Animal Management and Serum Sampling
Salmonid fish were maintained by each farm and subjected
to environmental factors specific to each geographical region
of Chile (X, XI, and XIV–IX). All sampling procedures were
authorized by the farming companies and performed according
National Fisheries Services guidelines and supervised by vet-
erinarians. Animal procedures were approved by Institutional
CICUAL (Translation: Comité Institucional de Cuidado y Uso de
Animales de Experimentación, Institutional Comiteé for care and
use of Animals for experimentation), which follows international
ethics guidelines and is composed of institutional experts and
external advisers. Blood samples were collected by each farm by
caudal venous puncture and then immediately transferred to a
tube and left for 24 h at 4°C for serum extraction. The average
number of sera obtained from each aquaculture center at a specific
time point after vaccination was 10. Samples were transported
according to proper biosafety procedures including appropriate
containments, cold chain monitoring and laboratory reception,
classification, and storage. Over 4 years, 32,399 serum samples
were collected from 622 Chilean farms at different periods after
vaccination. Forty-five percent of the sera were obtained from
Salmo salar, 34% from Oncorhynchus mykiss, and 21% from
Oncorhynchus kisutch. Most of sera were collected from sea-water
farms (74%) although some were collected from freshwater (20%)
and estuary (6%) farms. The average temperature of water of the
farms located in the X, XI, and XIV–IX regions of Chile was
11.73 0.13, 11.09 0.14, and 15.54 0.75°C, respectively. The
field study did not involve endangered or protected species.
Vaccination
The number of immunizations and type of vaccines utilized
in the study varied between the farms; however, at least one
injectable vaccine against SRS or ISAv was applied in all the
farms as primary vaccination. Some of these farms also per-
formed one or two oral vaccinations as booster immunization
in order to maintain immunity against the disease. On the
freshwater stage of growth, fish was first vaccinated by intraperi-
toneal (i.p) injection with an oil-adjuvanted commercial vac-
cine containing either P. salmonis or ISAv antigen. Fifty-five
percent of the farms utilized mono- or polyvalent injectable
vaccines provided by Virbac-Centrovet and the rest were from
other pharmaceuticals companies. Virbac-Centrovet injectable
vaccines were divided into monovalent (SRS – 9% of the farms
applied this type of vaccine), mixed [SRS+ infectious pancreatic
necrosis (IPN) – 28%], triple (SRS+ IPN+Vibrio ordalii – 9%),
tetravalent (SRS+ IPN+V. ordalii+ ISAv – 17%), or pentavalent
(SRS+ IPN+V. ordalii+ ISAv+Aeromonas salmonicida – 37%).
The injectable vaccines of other pharmaceutical companies were
categorized into mixed (29% of the farms applied this type of vac-
cine), triple (5%), tetravalent (24%), and pentavalent (39%). In the
saltwater growth stage, fish was immunized once or two times by
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oral route during 10 consecutive days, as previously reported (1).
The oral formulations used by the farms were mainly monovalent
(SRS – 78% and ISAv – 14%) or mixed (SRS+ ISAv – 8%) and
contained the inactivated SRS or ISAv antigen encapsulated in a
biological matrix licensed by Advance BioNutrition Corporation
(ABN). Among the farms, 42% only gave one booster; 44% gave
two boosters; and 14% gave more than two boosters. Each vaccine
was administrated according to the specifications stipulated by the
manufacturer.
IgM Purification
Twenty healthy and unvaccinated 30–50 g Atlantic salmons were
obtained from a local aquaculture facility and housed in Virbac-
Centrovet facilities at a density of 15 kg/m3 in tanks of 0.1m3. To
obtain the serum, fish were anesthetized in benzocaine 0.001% v/v
solution and bled through the caudal vein. Blood samples were left
overnight at 4°C and then centrifuged for 2min at 8000 rpm (7168
RCF). The sera were dialyzed against sterile phosphate buffered
saline solution (PBS – pH 7.4, 0.1M) and stored at  20°C until
use. Finally, IgM was separated by size-exclusion chromatography
(SEC) using sephacryl-S300 High-Resolution medium (GE Life
Sciences – GE Healthcare, Sweden). The resin was hydrated in
distilledwater and packed into a 100mL glass burette. The column
was washed twice with 300mL distilled water and equilibrated
with PBS using a peristaltic pump with constant flow rate of
0.5mL/min. The serum (15mL) was dialyzed against sterile PBS
before its loading, the elution fractions were collected every 1min
(0.5mL).
Dot Blot Analysis
Different elution fractions from SEC were placed onto nitro-
cellulose membrane and blocked overnight at 4°C with 2%
skimmed milk-in PBS. The membrane was washed three times
with PBS-Tween20 0.02%, incubated for 2 h at 37°C with mouse
monoclonal anti-salmon/IgM antibody (Clone 3H7/E1, diluted
1:1000 – GrupoBios, Chile) and again washed three times with
PBS-Tween20 0.02%. Finally, the membrane was incubated with
an anti-mouse IgG conjugated with peroxidase for 1 h at 37°C
(diluted 1:2000 – Sigma), washed three times and developed with
the ImmPACT DAB Kit SK-4105 kit (Vector Labs).
HPLC of IgM Fraction
Positive IgM fractions were analyzed by HPLC using an equili-
brated Atlantis Waters/250mm 10mm (10µm)/dC18 column
(Atlantis Columns) in Prominence LC-20A-HPLC-04 equipment
(Shimadzu, Japan). The sample was injected (20µL) and eluted
under isocratic conditions, acetonitrile/H2O 60:40. The column
was operated at 2.0mL/min flow rate, 27°C and 15 bar. The
presence of proteins was observed at 280 nm. The purified IgM
protein was quantified using a NanoQuant Infinite M200Pro
spectrophotometer (Tecan Group Ltd.).
IgM ELISA
To quantify the IgM concentration present in the serum of vac-
cinated fish, a standard curve using the purified IgM was devel-
oped. Briefly, serial twofold dilutions of purified IgM in car-
bonate buffer (NaHCO3 0.2M, pH 9.6) were incubated in 96-
well polystyrene plates (Thermo Scientific) at 37°C for 2 h. To
detect specific anti-P. salmonis and anti-ISAv specific antibodies
on vaccinated fish, the outer surface protein A (OspA) from P.
salmonis and the hemagglutinin (HA) and neuraminidase (NA)
from ISAv were used as recombinant antigens to coat the plate
(4°C – overnight), respectively. Unbound antigens or IgM were
removed with PBS-Tween20 0.05%. The plates were blocked with
2% skim milk-PBS for 2 h at room temperature (25°C). After
blocking, microplates were washed three times and 1/50-fold
dilution of each serum sample was added to the wells. Plates
were then washed and incubated with a mouse monoclonal anti-
salmon/IgM antibody for 2 h at 37°C (Clone 3H7/E1, diluted in
PBS 1:1000 – GrupoBios, Chile) and later with a horseradish
peroxidase-conjugated goat anti-mouse IgG antibody for 1 h at
37°C (diluted in PBS 1:2000). Finally, the plates were developed
using 3,3,5,50-Tetramethylbenzidine (TMB, 1mg/mL in DMSO)
at room temperature during 10min and the reaction was stopped
with 2M sulfuric acid. The absorbance was read at 450 nm using
the Expert Plus ELISA reader (Asys).
SRS Mortalities in the Field
The field data were obtained from a Chilean farm located in the
X region of Chile. S. salar was grown in 26 cages of 50,000 fish
each with an average weight of 1500 g. The vaccination program
of the farm established two vaccinations (injectable and oral)
against P. salmonis. SRS mortalities during the productive cycle
were evaluated by PCR and symptomatology.
Statistical Analysis
The results of the experiments were expressed as the means SE.
Comparisons between groups were made using One-way
ANOVA – Dunnet post-test. Statistical significance was defined
as a p value smaller than 0.05. Analyses were performed using
GraphPad Prism software (USA).
Results
Quantitative ELISA for Salmon IgM Determination
To quantify the antibody levels present in the serum of fish, the
IgM protein from S. salar was isolated and purified in order to
generate a quantitative ELISA assay to allow the conversion of
absorbance values into specific IgM concentrations. Serum sam-
ples from vaccinated Atlantic salmon were purified and prepared
to analysis by SEC. The presence of the IgM protein in the various
fractions was determined by a dot blot assays using a specific
monoclonal anti-IgM antibody. Dot blot analysis indicated that
the third eluted fraction contained most of the IgM protein (Data
not shown). This fraction was further analyzed and compared by
HPLC to determine its purity. The chromatograms in Figure 1
show that the purified IgM protein presents one homogeneous
main signal at an elution time of 5min. Finally, the IgM protein
was quantified and used as a standard in the ELISA test.
Detection of P. salmonis and ISAv Specific IgM
Antibodies on Vaccinated Fish
When the sera collected from fish at the different aquaculture
farms (immunizedwith a primary injection of a commercialmono
or polyvalent vaccine by i.p against SRS or ISAv) were analyzed
Frontiers in Immunology | www.frontiersin.org May 2015 | Volume 6 | Article 2443
Tobar et al. Oral immunizations protect salmonids
FIGURE 1 | Chromatography of purified IgM from S. salar. The IgM of Atlantic salmon previously separated by SEC was subjected to HPLC on dC18 column
(Waters) and eluted under isocratic conditions. The chromatography was monitored at 280 nm.
to detect anti-P. salmonis and anti-ISAv antibodies, the results
showed that specific IgM antibodies against both pathogens
increased significantly after vaccination. The highest IgM con-
centration post vaccination was observed between 600 and
800 degree-days (Figures 2A,B). Interestingly, after 1300 degree-
days, the IgM level against SRS and ISAv was not significantly
different from unvaccinated fish. A second immunization had
to be performed between 1300 and 1700 degree-days in order
to maintain a high-protective IgM level. The results indicated
that oral immunizations, given as a booster vaccination, rapidly
increased concentration of specific IgM antibodies in vaccinated
fish, maintaining the antibody response up to 2800–3200 degree-
days (Figures 3A,B). In that context, we studied the mortality
rate against SRS from one aquaculture center that performed
two immunizations, injectable and oral booster. The analysis
showed that both immunizations maintained a high level of anti-
bodies against SRS up to 3600 degree-days. However, when the
IgM concentration induced by the second vaccination decreased
(1500–2500 ng/mL), SRS and overall mortalities began to increase
(Figures 4A,B). In addition, an antimicrobial treatment was
applied close to the window of susceptibility in order to maintain
the protective state when the IgM concentration was decreasing.
The results showed that the antibiotic treatment did not prevent
the increase of SRS mortalities. In order to avoid the low concen-
tration of antibodies and the susceptibility window to SRS after
oral booster, some farms performed a third immunization (second
oral). The vaccinated fish rapidly augmented the IgM concentra-
tion up to an average of 6000 ng/mL between 3200–3400 degree-
days; however, the antibody titer and the duration of the immunity
diminished at 4000 degree-days (Figure 5).
Discussion
Vaccination is a cost-effective method for controlling infectious
diseases in aquaculture such as SRS and ISAv, and has been
demonstrated to significantly reduce disease outbreaks during
FIGURE 2 | Injectable vaccination increases IgM antibody titers.
Salmonids from different aquaculture industries were immunized i.p
(0.1mL/fish) with injectable mono or polyvalent vaccines against SRS (A) or
ISAv (B) from either Centrovet or other pharmaceutical companies. The IgM
concentration was followed up to 2000degree-days. Serum samples were
obtained at different degree-days to determine specific anti-P. salmonis and
anti-ISAv antibodies through a quantitative ELISA assay. The samples were
statistically analyzed by one-way ANOVA – Dunnet post-test. (SRS 120
fish/point, ISAv 65 fish/per point) *p<0.05; **p<0.01; ***p<0.001.
production. The study of the immune response of vaccinated fish
has been an area of particular interest in the last years. Indeed,
there is a growing demand to establish the protective status
of fish and determine how this correlates with immunological
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signatures after vaccination to provide evidence of the efficacy
and the protective state conferred by vaccines (11). This is
important not only at scientific level but also at productive level
FIGURE 3 | Oral immunizations increase antibody production. Fish were
immunized by injectable vaccines as primo-vaccination and later as booster
immunization by the oral route against SRS (A) and ISAv (B) infections. The
IgM level was followed up to 3000degree-days. The arrow indicates the
time-point where the oral vaccine was administrated. Samples were
statistically analyzed by one-way ANOVA – Dunnet post-test. (SRS 120
fish/point, ISAv 65 fish/per point) *p<0.05; **p<0.01; ***p<0.001.
FIGURE 5 | Several oral immunizations are required to maintain
a long-term protection against SRS. Salmonids from different
aquaculture industries were first immunized with an injectable mono or
polyvalent vaccine against SRS. The arrows at 1700 and
2900degree-days indicate the time-point where first and second oral
vaccines were administrated, respectively. Serum samples were
obtained at different degree-days to determine specific IgM anti-P.
salmonis. Samples were statistically analyzed by one-way
ANOVA – Dunnet post-test. (SRS 150 fish/point, ISAv 70 fish/per
point) *p<0.05; **p<0.01; ***p<0.001.
especially to reduce the cost/benefit ratio of massive vaccination
programs. The efficacy of vaccination has been often attributed
with specific antibody levels present on immunized fish.
FIGURE 4 | A decreased IgM concentration is associated with an
enhanced susceptibility to SRS infection. The IgM concentration and the
mortality rate were monitored on daily basis during the productive cycle. Fish
with SRS (A) or overall mortalities (B) was analyzed. SRS mortalities were
diagnosed by PCR and symptomatology. The arrows at 3200, 3700, and
4600degree-days indicate florfenicol administration.
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Although, correlate of protection against SRS and ISA is a topic
of discussion by the industry in Chile, recent studies have shown
that there is close association between specific IgM antibodies and
vaccine protection (12). Recently, it was demonstrated that rela-
tive percent survival (RPS) values can be associated with antibody
titers induced by vaccination (5). In the present study, we have
shown that to reduce SRS and ISA mortalities, several immuniza-
tions are necessary in order to maintain a high concentration of
specific IgMantibodies.Wedetermined that concentrations below
2000 ng/mL of specific anti-SRS IgM antibodies generate a sus-
ceptibility window that increases the probability of SRS outbreaks.
On the other hand, concentrations above 2500 ng/mLwere able to
confer protection from infection, indicating the close association
between protective antibodies and disease outbreak. Interestingly,
antibiotic treatment did not prevent SRS mortalities, indicating
that vaccination is crucial to avoid losses, especially against antibi-
otic resistant P. salmonis strains. Although the percentage of SRS
deaths was low, fish entered into susceptibility window where
other infections such as bacterial kidney disease (BKD), IPN,
caligus, and fungi may act (Figure 4). The high-antibody level
after vaccination together with the reduction of disease outbreaks
have been observed in several farms in Chile during three years of
the following up service.
The IgM analyses of vaccinated fish were consistent with the
notion that, in the field, injectable vaccines do not protect over
the entire productive cycle, which in our study was around
800 degree-days. Similarly, booster immunizations by oral admin-
istration have shown excellent results under experimental condi-
tions (1, 13). The success of oral vaccination is closely related with
the amount of antigen that is internalized and processed by fish
(14). Thus, oral vaccines have to protect the antigen from protease
degradation and gastric pH in order to activate the immune
system in the gut and other mucosal tissues. Our results indicated
that oral immunizations promoted a similar increment of anti-
body titers in comparison with injectable vaccine. In contrast to
injectable vaccines, oral vaccination has the advantage that it can
be used in large-scale procedures and during the complete sea-
water period, being an effective way to maintain the protective
state along the entire productive cycle (15).
The short-term protection induced by injectable and oral vac-
cines in the fieldmight be explained by the unique immune system
of salmonids. In teleost fish, the B cell response presents different
dynamics in terms of antibody response, affinity maturation and
immunological memory. The ability to generate highly specific
antibodies associated with the process of affinity maturation
occurs relatively late in the antibody response (16–19). The
immunological memory is one of the hallmarks of vaccination
and it is crucial to induce long-term protection. In mammals,
the immunological memory depends mostly on the presence of
memory B cells and the persistence of long-lived plasma cells
(LLPC) (20). In salmonids, it has been established that memory
B cells response occurs but in a much lesser degree in comparison
to mammals. Antigenic re-stimulation of these cells promotes
only arithmetic but not logarithmic increase of the antibody
titers upon second challenge with thymus-dependent antigens
(21). In the same line, our results showed that upon booster
immunizations the antibody titers tend to increase arithmeti-
cally in comparison with the first immunization. Recently, it was
demonstrated that the existence of LLPC in the anterior part of
the kidney in response to thymus-dependent and -independent
antigens (15). These cells provide a persistence humoral immune
response against pathogens due to the sustained liberation of high-
affinity antibodies (22, 23). The variability and limited duration
of antibody response after vaccination observed in this study
may be due to the lack of the appropriate physiological and
environmental conditions such as chemokines, cytokines, and
cell-to-cell contact, required to maintain these cells within the
anterior kidney (24, 25). Additional studies have to be done in
order to understand more the immunological memory in teleost
fish. In addition, the short-term protection promoted by vacci-
nation indicated that extrapolations of experimental conditions
on fish immune response to commercial productive conditions
are difficult to accomplish. The maintenance of a comprehensive
vaccination program will be crucial to prevent or nullify the risk
or susceptibility to infectious diseases. The knowledge that suc-
cessive immunizations are essential to maintain a protective state
until harvest on farmed salmonids will help producers to enhance
existing sanitary conditions and also to have a higher yield and
quality in their productions. Other analytics development such as
the identification and detection of different lymphocytes popula-
tions, cytokine profiles, and polarization of the immune response
and IgT determination will improve decision-making and in con-
sequence overall productivity of the farms.
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